Literature DB >> 19075194

Chronic kidney disease and hip fracture-related mortality in older people in the UK.

Dorothea Nitsch1, Adrian Mylne, Paul J Roderick, Liam Smeeth, Richard Hubbard, Astrid Fletcher.   

Abstract

BACKGROUND: Dialysis patients have increased hip fracture rates when compared to the general population of the same age and sex. There have been few studies of the association of earlier stages of chronic kidney disease (CKD) with hip fractures amongst older people in the general population. The aim of this study was to examine whether CKD at older ages is associated with hip-fracture-related mortality.
METHODS: In a trial of health and social assessment of people aged 75 and over in the UK with baseline assessment between 1995 and 1998, there were 13,177 (87%) participants in 53 general practices who had a serum creatinine measured at baseline. Estimated glomerular filtration rate (eGFR) was derived from the modification of diet in renal disease formula (MDRD). Mortality follow-up using linkage to national mortality data was until the end of November 2005. We used propensity scores to adjust for potential confounders in Cox regression models.
RESULTS: There were 84 hip-fracture-related deaths over a median follow-up of 7.25 years (IQR 3.79-8.77). Compared to eGFR 60 ml/min/1.73 m2 and above, the age- and sex-adjusted hazard ratio (HR) for hip-fracture-related death was 1.06 (95% confidence interval: 0.71, 1.58) for eGFR 45-59 and 1.98 (1.12, 3.50) for eGFR < 45. In adjusted models, the HR for eGFR < 45 ml/min/1.73 m2 compared to above was 1.81 (1.11, 2.96).
CONCLUSIONS: Amongst older people, an eGFR of <45 ml/ min/1.73 m2 is associated with an almost 2-fold increase in hip-fracture-related mortality.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19075194     DOI: 10.1093/ndt/gfn678

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  37 in total

1.  The clinical utility of FRAX to discriminate fracture status in men and women with chronic kidney disease.

Authors:  S A Jamal; S L West; T L Nickolas
Journal:  Osteoporos Int       Date:  2013-10-11       Impact factor: 4.507

2.  Skeletal levels of bisphosphonate in the setting of chronic kidney disease are independent of remodeling rate and lower with fractionated dosing.

Authors:  Elizabeth A Swallow; Mohammad W Aref; Corinne E Metzger; Spencer Sacks; Demi R Lehmkuhler; Neal Chen; Max A Hammond; Paul R Territo; Thomas L Nickolas; Sharon M Moe; Matthew R Allen
Journal:  Bone       Date:  2019-07-09       Impact factor: 4.398

3.  Skeletal accumulation of fluorescently tagged zoledronate is higher in animals with early stage chronic kidney disease.

Authors:  E A Swallow; M W Aref; N Chen; I Byiringiro; M A Hammond; B P McCarthy; P R Territo; M M Kamocka; S Winfree; K W Dunn; S M Moe; M R Allen
Journal:  Osteoporos Int       Date:  2018-06-11       Impact factor: 4.507

4.  Fracture Burden and Risk Factors in Childhood CKD: Results from the CKiD Cohort Study.

Authors:  Michelle R Denburg; Juhi Kumar; Thomas Jemielita; Ellen R Brooks; Amy Skversky; Anthony A Portale; Isidro B Salusky; Bradley A Warady; Susan L Furth; Mary B Leonard
Journal:  J Am Soc Nephrol       Date:  2015-07-02       Impact factor: 10.121

5.  Moderate chronic kidney disease impairs bone quality in C57Bl/6J mice.

Authors:  Chelsea M Heveran; Alicia M Ortega; Andrew Cureton; Ryan Clark; Eric W Livingston; Ted A Bateman; Moshe Levi; Karen B King; Virginia L Ferguson
Journal:  Bone       Date:  2016-02-06       Impact factor: 4.398

Review 6.  Bone Health in Glomerular Kidney Disease.

Authors:  Dorey A Glenn; Michelle R Denburg
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

7.  Discriminants of prevalent fractures in chronic kidney disease.

Authors:  Thomas L Nickolas; Serge Cremers; Amy Zhang; Valeri Thomas; Emily Stein; Adi Cohen; Ryan Chauncey; Lucas Nikkel; Michael T Yin; Xiaowei S Liu; Stephanie Boutroy; Ronald B Staron; Mary B Leonard; Donald J McMahon; Elzbieta Dworakowski; Elizabeth Shane
Journal:  J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 10.121

8.  Chronic kidney disease and aging differentially diminish bone material and microarchitecture in C57Bl/6 mice.

Authors:  Chelsea M Heveran; Charles A Schurman; Claire Acevedo; Eric W Livingston; Danielle Howe; Eric G Schaible; Heather B Hunt; Adam Rauff; Eve Donnelly; R Dana Carpenter; Moshe Levi; Anthony G Lau; Ted A Bateman; Tamara Alliston; Karen B King; Virginia L Ferguson
Journal:  Bone       Date:  2019-05-02       Impact factor: 4.398

9.  Rapid cortical bone loss in patients with chronic kidney disease.

Authors:  Thomas L Nickolas; Emily M Stein; Elzbieta Dworakowski; Kyle K Nishiyama; Mafo Komandah-Kosseh; Chiyuan A Zhang; Donald J McMahon; Xiaowei S Liu; Stephanie Boutroy; Serge Cremers; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2013-08       Impact factor: 6.741

Review 10.  Transcriptomics: a Solution for Renal Osteodystrophy?

Authors:  Aline Martin; Valentin David
Journal:  Curr Osteoporos Rep       Date:  2020-06       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.